| Literature DB >> 28652516 |
Masayuki Uchida1, Orie Kobayashi1, Kimiko Shimizu1.
Abstract
Background This study aimed to evaluate the effects of the position of an acetic acid-induced gastric ulcer and the effects of prokinetic drugs on gastric emptying. Materials and Methods Male Sprague-Dawley rats were used in this study. Acetic acid ulcers were induced either in the region between the fundus and pylorus on the anterior wall of the stomach or in the glandular region on the greater curvature of the stomach to determine whether there were regional differences in the effect of the ulcers. Gastric emptying was evaluated with a breath test using [1-13C] acetic acid. In addition, the effects of the prokinetic drugs, metoclopramide and mosapride, on gastric emptying were also evaluated. Results Acetic acid induced ulcers in the region between the fundus and pylorus on the anterior wall of the stomach significantly delayed gastric emptying as compared with control rats, but not the acetic acid induced ulcers in the glandular region on the greater curvature of the stomach. Metoclopramide and mosapride did not improve the delayed gastric emptying even at doses that enhanced gastric emptying in normal rats. Conclusion These findings show that gastric emptying is influenced by the position of the ulcer and the region between the fundus and pylorus on the anterior wall plays an important role in gastric emptying. Moreover, it was found that metoclopramide and mosapride do not improve the delayed gastric emptying caused by acetic acid ulcers induced on the anterior wall in the region between the fundus and pylorus.Entities:
Keywords: 13C-Breath test in rats; Gastric emptying; gastric ulcer; metoclopramide; mosapride
Mesh:
Substances:
Year: 2017 PMID: 28652516 PMCID: PMC5487827 DOI: 10.1540/jsmr.53.48
Source DB: PubMed Journal: J Smooth Muscle Res ISSN: 0916-8737
Fig. 1.Schematic representation of the ulcerated regions between the fundus and pylorus on the anterior wall (antral ulcer) or in the glandular region on the greater curvature of the rat stomach (corpus ulcer).
Fig. 2.Schematic representation of the criteria of the breathe test. Δ13CO2 values were plotted against the time after test meal administration. The maximum concentration (Cmax; ‰), the time taken to reach the maximum concentration (Tmax; min) and the area under the curve (AUC120 min; ‰·min) were calculated using measured Δ13CO2 values.
Fig. 3.The change of expired 13CO2 in rats with (▲) and without (●) the corpus ulcers. Values represent the mean ± standard error of the mean (n = 4 or 5). No significant differences were observed between two groups.
Pharmacokinetic parameters of the changes in the levels of expired 13CO2 in rats with and without the corpus ulcers
| AUC120 min (‰ ∙ min) | |||
| Control | 202.4 ± 24.1 | 38.8 ± 3.2 | 16,396 ± 1,613 |
| Corpus ulcer | 206.8 ± 12.2 | 45.0 ± 3.7 | 16,848 ± 785 |
Values represent the mean ± standard error of the mean (n = 4 or 5). No significant differences were observed as compared with control group.
Fig. 4.The change of expired 13CO2 in rats with (■) and without (●) the antral ulcers. Values represent the mean ± standard error of the mean (n = 4). *, **: Significant difference from the control (P<0.05, 0.01).
Pharmacokinetic parameters of the changes in the levels of expired 13CO2 in rats with and without the antral ulcers
| AUC120 min (‰ ∙ min) | |||
| Control | 264.9 ± 15.5 | 33.8 ± 3.1 | 21,188 ± 759 |
| Antral ulcer | 201.2 ± 31.6 | 57.5 ± 4.3** | 19,751 ± 1,474 |
Values represent the mean ± standard error of the mean (n = 4). **: Significant difference from the control group (P<0.01)
Fig. 5.The effects of metoclopramide (■) or mosapride (▲) on the change of expired 13CO2 in rats having antral ulcers. Values represent the mean ± standard error of the mean (n = 4). No significant differences were observed as compared with the control (●).
Effects of metoclopramide or mosapride on the pharmacokinetic parameters of the changes in the levels of expired 13CO2 in rats having antral ulcers
| AUC120 min (‰ ∙ min) | |||
| Control | 237.8 ± 25.8 | 42.5 ± 2.5 | 19,394 ± 877 |
| Metoclopramide | 239.4 ± 12.5 | 41.2 ± 2.4 | 21,475 ± 1,213 |
| Mosapride | 256.2 ± 25.8 | 42.5 ± 1.4 | 21,818 ± 1,629 |
Values represent the mean ± standard error of the mean (n = 4). No significant differences were observed as compared with the control.